The US FDA has approved Pfizer’s Zavzpret nasal spray for migraines

The US FDA has approved Pfizer’s Zavzpret nasal spray for migraines

Zavzpret (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray, has been approved by the US Food and Drug Administration (FDA) for the immediate treatment of migraine in adults with or without aura. Zavzpret was statistically…